The individualized choice of embryo transfer timing for patients with elevated serum progesterone level on the HCG day in IVF/ICSI cycles: A prospective randomized clinical study

Gynecological Endocrinology

Volumn 31, Issue 5, 2015, Pages 355-358

  Yang, Shuo ^a   Pang, Tianshu ^a   Li, Rong ^a   Yang, Rui ^a   Zhen, Xiumei ^a   Chen, Xinna ^a   Wang, Haiyan ^a   Ma, Caihong ^a   Liu, Ping ^a   Qiao, Jie ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Blastocyst; Elevated progesterone; Frozen; HCG administration; in vitro fertilization

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; PROGESTERONE; AGENTS ACTING ON THE GENITAL SYSTEM; ESTRADIOL; ESTROGEN; GESTAGEN;

ADULT; ARTICLE; BLASTOCYST; CONTROLLED STUDY; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FREEZE THAWING; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; NIDATION; OOCYTE RETRIEVAL; PERSONALIZED MEDICINE; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; BLOOD; CRYOPRESERVATION; INFERTILITY, FEMALE; PREGNANCY; PROCEDURES; TIME; YOUNG ADULT;

ADULT; BLASTOCYST; CHORIONIC GONADOTROPIN; CRYOPRESERVATION; EMBRYO TRANSFER; ESTRADIOL; ESTROGENS; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY RATE; PROGESTERONE; PROGESTINS; REPRODUCTIVE CONTROL AGENTS; SPERM INJECTIONS, INTRACYTOPLASMIC; TIME FACTORS; YOUNG ADULT;

EID: 84931424128     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.995620     Document Type: Article

References (21)

1. Van Vaerenbergh I, Fatemi HM, Blockeel C, et al. Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression. Reprod Biomed Online 2011;22: 263-71.
2. Ochsenkühn R, Arzberger A, von Schönfeldt V, et al. Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers. Fertil Steril 2012;98:347-54.
3. Nayak S, Ochalski ME, Fu B, et al. Progesterone level at oocyte retrieval predicts in vitro fertilization success in a short-antagonist protocol: a prospective cohort study. Fertil Steril 2014;101:676-82.
4. Li R, Qiao J, Wang L, et al. Serum progesterone concentration on day of HCG administration and IVF outcome. Reprod Biomed Online 2008;16:627-31.
5. Bu Z, Zhao F, Wang K, et al. Serum progesterone elevation adversely affects cumulative live birth rate in different ovarian responders during in vitro fertilization and embryo transfer: a large retrospective study. PLoS One 2014;9:e 100011.
6. Venetis CA, Kolibianakis EM, Bosdou JK, et al. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update 2013;19:433-57.
7. Lahoud R, Kwik M, Ryan J, et al. Elevated progesterone in GnRH agonist down regulated n vitro fertilisation (IVFICSI) cycles reduces live birth rates but not embryo quality. Arch Gynecol Obstet 2012; 385:535-40.
8. Xu B, Li Z, Zhang H, et al. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10 000 cycles. Fertil Steril 2012; 97:1321-7.
9. Elgindy EA. Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy. Fertil Steril 2011;95:1639-44.
10. Orvieto R, Nahum R, Meltzer S, et al. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels. Gynecol Endocrinol 2013;29:843-5.
11. Edelstein MC, Seltman HJ, Cox BJ, et al. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril 1990;545:853-7.
12. Andersen CY, Bungum L, Andersen AN, et al. Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate. Reprod Biomed Online 2011;23:187-95.
13. Andersen CY, Bungum L, Andersen AN, et al. Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate. Reprod Biomed Online 2011;23:187-95.
14. Al-Azemi M, Kyrou D, Kolibianakis EM, et al. Elevated progesterone during ovarian stimulation for IVF. Reprod Biomed Online 2012;24:381-8.
15. Moffitt DV, Queenan JT, Shaw R, et al. Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort. Fertil Steril 1997;67:296-301.
16. Urman B, Alatas C, Aksoy S, et al. Elevated serum progesterone level on the day of human chorionic gonadotropin administration does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo transfer. Fertil Steril 1999;72: 975-9.
17. Wu Z, Li R, Ma Y, et al. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles. Reprod Biomed Online 2012;24:511-20.
18. Check JH, Wilson C, Choe JK, et al. Evidence that high serum progesterone (P) levels on day of human chorionic gonadotropin (hCG) injection have no adverse effect on the embryo itself as determined by pregnancy outcome following embryo transfer using donated eggs. Clin Exp Obstet Gynecol 2010;37:179-80.
19. Rijnders PM, Jansen CAM. The predictive value of day 3 embryo morphology regarding blastocyst formation, pregnancy and implantation rate after day 5 transfer following in-vitro fertilization or intracytoplasmic sperm injection. Hum Reprod 1998;13:2869-73.
20. Glujovsky D, Blake D, Bardach A, et al. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology (Review). Cochrane Database Syst Rev 2012.
21. Corti L, Papaleo AE, Pagliardini L, et al. Fresh blastocyst transfer as a clinical approach to overcome the detrimental effect of progesterone elevation at hCG triggering: a strategy in the context of the Italian law. Eur J Obstet Gynecol Reprod Biol 2013;171:73-7.